Statistics for the 2023 Castrate-Resistant Prostate Cancer market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Castrate-Resistant Prostate Cancer analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry...
BMC Urology(2023) Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer Masashi Oshima Ken-ichi Takayama Satoshi Inoue Scientific Reports(2023) Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US,...
Advanced prostate and bladder cancer are two outstanding unmet medical needs for urological oncologists. The high prevalence of these tumours, lack of effective biomarkers and limited effective treatment options highlight the importance of basic research in these diseases. Galectins are a family of β...
affecting nearly 1.6 million individuals with more than 3,00,000 deaths worldwide [3]. Reports showed that it is the second most commonly identified cancer in males and the fifth major cause of cancer-related death [4]. In India, PC was one of the most frequently detected cancers in 2020...
e17086#Background:The survival benefit of upfront triplet therapy in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has been demonstrated in two prospective randomised trials using a combination of androgen deprivation therapy (ADT), docetaxel and an androgen receptor signalling ...
Sign inJournal of Advanced Research Volume 51, September 2023, Pages 197-217ReviewBiomolecule-functionalized nanoformulations for prostate cancer theranostics Author links open overlay panelPranav, Partha Laskar, Meena Jaggi, Subhash C. Chauhan, Murali M. YallapuShow more Add to Mendeley Share Cite ...
ESMO guidelines Pan-Asian prostate cancer treatment Sorry, something went wrong. Please try again and make sure cookies are enabledReferences 1 H. Sung, J. Ferlay, R.L. Siegel, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185...
Interestingly, HVJ-E-induced apoptosis was significantly increased by an inducer of autophagy, rapamycin pretreatment, both in vitro and in vivo. Conclusion HVJ-E exerts anticancer effects via autophagic cell death in prostate cancer cells. Keywords: Inactivated Sendai virus (HVJ-E), Reactive ...
Human prostate cancer is a complex heterogeneous disease that mainly affects elder male population of the western world with a high rate of mortality. Acquisitions of diverse sets of hallmark capabilities along with an aberrant functioning of androgen re
Nature Medicine volume 29, pages 888–897 (2023)Cite this article 6359 Accesses 47 Citations 231 Altmetric Metrics details Abstract B7 homolog 3 (B7-H3; CD276), a tumor-associated antigen and possible immune checkpoint, is highly expressed in prostate cancer (PCa) and is associated with early...